Close Menu

NanoString

NanoString and Broad will investigate molecular networks involved in immune response and other biological processes, and will explore potential new applications for NanoString's digital gene expression technology.

Developed by the External RNA Controls Consortium, an ad hoc group of participants from industry, the government, and academia, the spike-in RNA controls will be designed to enable researchers to measure the performance of their assays.

In Print: Jul 14, 2009

Premium

Microarray-related Papers of Note Published in June 2009

With access to nearly every major array platform as well as other technologies, Toumy Guettouche, the manager of the University of Miami's Oncogenomics Core Facility, has a good view of the changing genomic tool landscape.

The firm will use the funds to accelerate commercialization of its nCounter Analysis System for research and diagnostic applications.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.